Delivery Order SPE2DB22D3301-SPE2DB25FZ1PV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,847.08 to AmerisourceBergen Drug Corp for the supply of Sildenafil 20 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,167.06 to AmerisourceBergen Drug Corp for Sildenafil 20 mg tablets (90-count supply) on August 28, 2025, with a completion date of August 29, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $9,112.24 to supply Sildenafil 20 mg tablets (90-count units) with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,025.19 to AmerisourceBergen Drug Corp for the supply of Sildenafil 20 mg tablets (90-unit quantity) under a firm fixed-price contract type. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $283,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sildenafil 100 mg tablets. Under this order, Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by August 28, 2023 in support of the Department of Defense's medical supply needs. As a leading distributor of pharmaceuticals and medical supplies, Amerisourcebergen routinely fulfills delivery orders under the DLA's Prime Vendor Program on...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $21,600 to Amerisourcebergen Drug Corporation for the supply of 100mg sildenafil tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility located in Conshohocken, Pennsylvania, under a period of performance spanning July 19-20, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely procures pharmaceuticals in support of military...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $368.34 to Amerisourcebergen Drug Corp for the supply of 4561453186 Sildenafil 20 mg tablets in quantities of 30 tablets. Amerisourcebergen Drug Corp will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 11, 2023 to support the Defense Logistics Agency's medical supply needs. As the prime contractor, Amerisourcebergen Drug Corp will leverage its parent company Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Tadalafil 20 mg tablets (60-count) under a firm fixed-price contract valued at $75,995.63, with completion scheduled for September 8, 2025. This non-set-aside delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at one hundred thirty dollars and seventy cents ($130.70) to supply one hundred (100) tablets of 100mg sildenafil. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, spanning from August 28th through 29th, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,448,698 Sildenafil 20 mg tablets. The contract has a potential value of $19,247.07 and a completion date of January 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and serves as the main supplier of pharmaceutical products and medical supplies to the...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1PVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Sildenafil 20 mg tablets (90-count) under a firm fixed price contract valued at $14,726.76. This non-set-aside delivery order is scheduled for completion by September 26, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of competitively awarded contracts. The company demonstrates significant capability in fulfilling diverse federal pharmaceutical supply requirements, having consistently delivered delivery orders on a firm fixed price basis across multiple therapeutic domains. This award is part of AmerisourceBergen's ongoing role as a pharmaceutical prime vendor for the Defense Health Agency and other federal healthcare systems, contributing to the DLA's strategic initiative to maintain robust medical supply chains supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 9/25/25 |